Events > Understanding your early-stage breast cancer diagnosis

Understanding your early-stage breast cancer diagnosis

featured_paragraph

Receiving a breast cancer diagnosis can be overwhelming and disorienting. From test results to treatment choices to the questions you forgot to ask at your appointment, there is a lot of information to manage and process. You may be asking yourself: How do I tackle this? Where do I start?

general_content

Event details

During this webinar, Pallav Mehta, MD, a medical oncologist, discusses what you need to know about early-stage breast cancer when you’re newly diagnosed. Dr. Mehta is joined by Julia Wilson, who was diagnosed with early-stage breast cancer in 2017. Julia shares what was most helpful when she was newly diagnosed and what she wishes she learned earlier. We hope this webinar empowers you with the information you need now and offers resources to help you learn more in the future.

video

related_resources_article_carousel

Related resources

12/01/23 | BY: Reshma L. Mahtani

TC (Taxotere and cyclophosphamide) is a common chemotherapy regimen given for localized breast cancers that require chemotherapy.

| 5 Min. Read | 25

12/01/23 | BY: Reshma L. Mahtani

AC (Adriamycin and Cyclophosphamide) is a common chemotherapy regimen usually given for localized breast cancers.

| 3 Min. Read | 14

AC-T

12/01/23 | BY: Reshma L. Mahtani

AC-T (doxorubicin and cyclophosphamide followed by paclitaxel), also called AC-T and AC-Taxol, is a chemotherapy combination treatment used to treat breast cancer.

| 6 Min. Read | 12

Lymph node surgery

10/10/23 | BY: Oluwadamilola Fayanju, Carla S. Fisher

If you have an invasive breast cancer, your surgeon will need to check for cancer in one or several lymph nodes in the armpit on the side of the body where the cancer was found.

| 6 Min. Read

Recently diagnosed

10/10/23 | BY: LBBC Staff

Receiving a breast cancer diagnosis can be disorienting. Trying to process intense feelings, understand test results, and make treatment choices all at the same time is overwhelming. Learning about your diagnosis and treatment options can bring a greater feeling of control. We're here to help.

| 8 Min. Read | 3

Biopsy

10/10/23 | BY: Oluwadamilola Fayanju, Carla S. Fisher, Lauren Ende Schwartz

A biopsy involves taking a small amount of tissue from your breast. This tissue is then analyzed by a pathologist, a doctor who specializes in diagnosing disease. The pathologist looks at the sample of your tissue under a microscope to see if it has any cancer cells.

| 7 Min. Read | 1

Surgery

10/10/23 | BY: Vivian J. Bea, Oluwadamilola Fayanju, Monique Gary

Almost everyone diagnosed with breast cancer has some surgery. Surgery is a local therapy: a treatment that’s focused on a specific part of the body.

| 26 Min. Read | 3

Lumpectomy

10/10/23 | BY: Vivian J. Bea, Oluwadamilola Fayanju

Lumpectomy surgery is a breast-conserving treatment that removes cancer while allowing you to keep some or most of your natural breast tissue. Lumpectomy surgery is sometimes called partial mastectomy, because only a part of the breast is removed.

| 22 Min. Read | 16

Mammogram

08/28/23 | BY: Kristin Brill

Mammograms are x-ray examinations of the breasts used to screen for breast cancer and to evaluate breast changes that could be cancer.

| 18 Min. Read | 1

Targeted therapy

05/01/23 | BY: Stephanie Graff

Targeted therapies are treatments that target specific proteins or markers on or within cancer cells that help the cells to grow. They look for a specific feature of a cancer cell, attach to it, and destroy it. Only cancers with that feature will respond to the therapy.

| 8 Min. Read | 3

speakers_feature

About our experts

Pallav Mehta, MD

Pallav Mehta, MD, is the director of integrative oncology and director of practice development at the MD Anderson Cancer Center at Cooper in Camden, New Jersey. He is a medical oncologist/hematologist with expertise and interest in breast cancer and integrative oncology and is board certified in oncology, hematology and integrative medicine. He is a member of Living Beyond Breast Cancer’s Board of Directors.

Julia Wilson

Julia Wilson was diagnosed with stage I, HER2-positive breast cancer at the age of 35. Julia underwent a lumpectomy to remove her tumor, followed by six rounds of chemotherapy, 36 rounds of radiation, and 1 year of trastuzumab (Herceptin) infusions. She is a former Living Beyond Breast Cancer staff member and remains involved with the organization through her volunteer work.

upcoming_events